You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative Neoplasm

Showing 1 - 25 of 899
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Epidemiological and Clinical-pathological Factors of

    Completed
    • Myeloproliferative Neoplasm
    • +4 more
      • Guayaquil, Guayas, Ecuador
        Sociedad de Lucha Contra el Cáncer
      Apr 25, 2023

      Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

      Completed
      • Myelodysplastic/Myeloproliferative Neoplasm
      • +2 more
      • Decidual stromal cells (DSC)
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

      Not yet recruiting
      • Myeloproliferative Disorders
      • Leukemia
      • Cardiac Lifestyle Program
      • Boston, Massachusetts
      • +2 more
      May 1, 2023

      Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

      Withdrawn
      • Accelerated Phase MPN
      • Blast Phase MPN
      • (no location specified)
      Nov 4, 2022

      Epigenetic Age on Clinic-biological Presentation and Prognosis

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Assessment of the epigenetic age
      • Bordeaux, France
        CHU de Bordeaux, service Hématologie Biologique
      Aug 28, 2023

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Carotid Plaque Burden in Philadelphia Negative

      Recruiting
      • Myeloproliferative Neoplasm
        • Sohag, Egypt
          Faculty of Medicine
        Aug 14, 2023

        Myeloproliferative Tumor Trial in Irvine (Diet intervention)

        Completed
        • Myeloproliferative Neoplasm
        • Diet intervention
        • Irvine, California
          University of California, Irvine
        Jun 16, 2022

        Action of Interferon in Treatment of Myeloproliferative

        Recruiting
        • Myeloproliferative Neoplasm
          • Villejuif, Ile De France, France
            Inserm U1287
          Apr 28, 2023

          Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

          Not yet recruiting
          • Acute Myeloid Leukemia
          • +5 more
          • Cytokine Induced Memory-like Natural Killer Cells
          • Interleukin-2
          • Boston, Massachusetts
          • +1 more
          Nov 14, 2023

          Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

          Recruiting
          • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
          • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Jan 6, 2023

          Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

          Recruiting
          • Chronic Myelomonocytic Leukemia
          • +5 more
          • Houston, Texas
            M D Anderson Cancer Center
          May 23, 2022

          Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

          Recruiting
          • Myeloproliferative Neoplasm
          • Fedratinib Pill
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 28, 2022

          Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

          Not yet recruiting
          • Myelofibrosis
          • +2 more
          • Peptide-based vaccine
          • Poly ICLC
          • New York, New York
            Icahn School of Medicine at Mount Sinai
          Jun 7, 2022

          Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

          Recruiting
          • Acute Myeloid Leukemia
          • +8 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Aug 18, 2022

          Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

          Active, not recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Orange, California
            Chao Family Comprehensive Cancer Center, University of Californi
          Jan 6, 2023

          Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

          Not yet recruiting
          • Myeloproliferative Neoplasm
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Centre
          Apr 12, 2022

          Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

          Not yet recruiting
          • Bone Marrow Fibrosis
          • Myeloproliferative Neoplasm
          • Cleveland, Ohio
            Cleveland Clinic, Case Comprehensive Cancer Center
          Jan 30, 2023

          Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)

          Recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Blood sample
          • Amiens, Picardie, France
            Centre Hospitalier Universitaire d'Amiens
          Jan 27, 2023

          Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

          Recruiting
          • Myeloproliferative Neoplasm
          • +5 more
          • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
          • Aspirin 81 mg
          • Ottawa, Ontario, Canada
            The Ottawa Hospital
          Apr 19, 2022

          Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

          Not yet recruiting
          • Myeloid Malignancy
          • +4 more
          • Telehealth Serious Illness Care Program
          • Education Control
          • Rochester, New York
            University of Rochester
          May 24, 2023

          Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

          Not yet recruiting
          • Chronic Myelomonocytic Leukemia
          • +3 more
          • Biospecimen Collection
          • +3 more
          • (no location specified)
          Oct 27, 2022

          Monocytes Sub-populations in Thrombosis Associated With

          Recruiting
          • Myeloproliferative Neoplasm
          • 1 additional tube of blood
          • Bordeaux, France
          • +4 more
          Nov 30, 2022